Table 1.
Group | Control | svPPA |
---|---|---|
N (female) | 19 (12) | 13 (7) |
Age (SE, Range) | 65.2 (1.71, 53–78) | 61.8 (2.06, 49–71) |
Education (SE, Range) | 15.6 (0.60, 12–20) | 16.5 (0.75, 12–22) |
Duration from symptom onset (SE, Range) | -- | 3.69 (0.12, 1–9) |
MMSE (SE, Range)* | 29.6 (0.16, 28–30) | 22.7 (1.72, 14–30) |
BNT Mean Z-score (N<−1.96, Range) | -- | −14.7 (13, −16.1– −9.07) |
Animals Mean Z-score (N<−1.96, Range) | -- | −2.25 (11, −3.23– −0.80) |
Digit Span Forward Z-score (N<−1.96, Range) | -- | −0.54 (1, −3.14–0.83) |
Digit Span Reverse Z-score (N<−1.96, Range) | -- | −1.22 (2, −3.73–0.35) |
Significant differences between controls and patients with svPPA indicated by * (p=0.002 using independent samples t-test). Patient z-scores for cognitive measures relative to healthy control data (z-score < −1.96 equivalent to p<0.05).
Abbreviations: N=number; SE=standard error; svPPA=semantic variant primary progressive aphasia; MMSE=mini-mental state examination; BNT=Boston naming test; N<−1.96=number of patients scoring significantly worse than controls (p<0.05)